BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18335185)

  • 1. Involvement of (pro)renin receptor in the glomerular filtration barrier.
    Ichihara A; Sakoda M; Kurauchi-Mito A; Kaneshiro Y; Itoh H
    J Mol Med (Berl); 2008 Jun; 86(6):629-35. PubMed ID: 18335185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The (pro)renin receptor and the kidney.
    Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M; Itoh H
    Semin Nephrol; 2007 Sep; 27(5):524-8. PubMed ID: 17868789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin, prorenin and the kidney: a new chapter in an old saga.
    Ichihara A; Sakoda M; Kurauchi-Mito A; Kaneshiro Y; Itoh H
    J Nephrol; 2009; 22(3):306-11. PubMed ID: 19557706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated prorenin as a therapeutic target for diabetic nephropathy.
    Ichihara A; Sakoda M; Mito-Kurauchi A; Itoh H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S63-6. PubMed ID: 18922597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage.
    Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M; Nakagawa T; Nishiyama A; Kawachi H; Shimizu F; Inagami T
    J Am Soc Nephrol; 2006 Sep; 17(9):2495-503. PubMed ID: 16885412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocytes as a target of prorenin in diabetes.
    Sakoda M; Itoh H; Ichihara A
    Curr Diabetes Rev; 2011 Jan; 7(1):17-21. PubMed ID: 21067509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology.
    Nguyen G
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):129-33. PubMed ID: 17293688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Pro)renin receptors: are they biologically relevant?
    Danser AH
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):74-8. PubMed ID: 19077693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.
    Kaneshiro Y; Ichihara A; Sakoda M; Takemitsu T; Nabi AH; Uddin MN; Nakagawa T; Nishiyama A; Suzuki F; Inagami T; Itoh H
    J Am Soc Nephrol; 2007 Jun; 18(6):1789-95. PubMed ID: 17494887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension.
    Ichihara A; Kaneshiro Y; Suzuki F
    Expert Opin Investig Drugs; 2006 Oct; 15(10):1137-9. PubMed ID: 16989590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
    Sakoda M; Ichihara A; Kurauchi-Mito A; Narita T; Kinouchi K; Murohashi-Bokuda K; Saleem MA; Nishiyama A; Suzuki F; Itoh H
    Am J Hypertens; 2010 May; 23(5):575-80. PubMed ID: 20075844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin receptor blockade: a better strategy for renal protection than renin-angiotensin system inhibition?
    Müller DN; Luft FC
    Curr Hypertens Rep; 2008 Oct; 10(5):405-9. PubMed ID: 18775120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro)renin receptor: promising young players from the old renin-angiotensin-aldosterone system.
    Balakumar P; Jagadeesh G
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):570-9. PubMed ID: 21108514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(Pro) renin receptor].
    Ichihara A; Ito H
    Nihon Rinsho; 2009 Apr; 67(4):675-80. PubMed ID: 19348227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Pro)renin receptor and autophagy in podocytes.
    Ichihara A
    Autophagy; 2012 Feb; 8(2):271-2. PubMed ID: 22301996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Updates on the Proximal Tubule Renin-Angiotensin System in Angiotensin II-Dependent Hypertension.
    Li XC; Zhuo JL
    Curr Hypertens Rep; 2016 Aug; 18(8):63. PubMed ID: 27372447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide.
    Ichihara A; Sakoda M; Kurauchi-Mito A; Narita T; Kinouchi K; Itoh H
    J Pharmacol Sci; 2009 Jan; 109(1):20-3. PubMed ID: 19151536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic roles of prorenin and (pro)renin receptor in the eye.
    Satofuka S; Ichihara A; Nagai N; Tsubota K; Itoh H; Ishida S
    Front Biosci; 2008 May; 13():3884-95. PubMed ID: 18508482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The (pro)renin receptor: a new addition to the renin-angiotensin system?
    Batenburg WW; Jan Danser AH
    Eur J Pharmacol; 2008 May; 585(2-3):320-4. PubMed ID: 18417113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
    Ichihara A; Suzuki F; Nakagawa T; Kaneshiro Y; Takemitsu T; Sakoda M; Nabi AH; Nishiyama A; Sugaya T; Hayashi M; Inagami T
    J Am Soc Nephrol; 2006 Jul; 17(7):1950-61. PubMed ID: 16738017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.